Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Pappas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinics in Liver Disease|October 1, 2021
Hepatitis B and Health Care WorkersStephen C Pappas
Intensive Care Medicine|October 23, 2024
Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosisFlorence Wong, Stephen C Pappas
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 20, 2018
Predictors of Response to Terlipressin in Hepatorenal SyndromeAyse L Mindikoglu, Stephen C Pappas
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
New Developments in Hepatorenal SyndromeAyse L Mindikoglu, Stephen C Pappas
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 25, 2015
Curbside Consultations: The Good, the Bad, and the UglyMichael Lin, Stephen C Pappas, Joseph Sellin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2019
Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndromeFlorence Wong, Thomas D Boyer, Arun J Sanyal, et al.
Hepatology (Baltimore, Md.)|March 3, 2010
Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirinMoises Diago, Mitchell L Shiffman, Jean-Pierre Bronowicki, et al.
Journal of Hepatology|September 10, 2002
Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)Samuel S Lee, E Jenny Heathcote, K Rajender Reddy, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinics in Liver Disease|October 1, 2021
Hepatitis B and Health Care WorkersStephen C Pappas
Intensive Care Medicine|October 23, 2024
Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosisFlorence Wong, Stephen C Pappas
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 20, 2018
Predictors of Response to Terlipressin in Hepatorenal SyndromeAyse L Mindikoglu, Stephen C Pappas
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
New Developments in Hepatorenal SyndromeAyse L Mindikoglu, Stephen C Pappas
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 25, 2015
Curbside Consultations: The Good, the Bad, and the UglyMichael Lin, Stephen C Pappas, Joseph Sellin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2019
Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndromeFlorence Wong, Thomas D Boyer, Arun J Sanyal, et al.
Hepatology (Baltimore, Md.)|March 3, 2010
Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirinMoises Diago, Mitchell L Shiffman, Jean-Pierre Bronowicki, et al.
Journal of Hepatology|September 10, 2002
Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD)Samuel S Lee, E Jenny Heathcote, K Rajender Reddy, et al.
Pageof 1